![Drug manufacturing laboratory equipment](https://www.nortonrosefulbright.com/-/media/images/nrf/thought-leadership/canada/publications/life-sciences-healthcare-lab-equipment.jpg?w=265&revision=355955d3-b814-40be-80c7-63b3ad62cb43&revision=5248910870347387904&hash=1F3BEDB56F2489EB29C4E2FCBDED3656)
Publication
Health Canada identifies lithium-ion batteries, infant bath seats, and water beads as hazards of concern
Health Canada has recently identified three new classes of products that pose a hazard of concern.
United Kingdom | Publication | June 2022
Statutory guidance on the preparation of implementation statements has been issued following a consultation that closed earlier this year. The new statutory guidance will apply to implementation statements prepared in respect of any scheme year ending on or after October 1, 2022.
Key points to note include that additional information on the voting behaviour and policies of asset managers will be required, including more detailed explanations of how these align with the scheme’s stewardship policies and how managers are monitored by trustees.
In addition to the statutory guidance that must be complied with, non-statutory guidance on the preparation of the statement of investment principles has also been released alongside this – trustees should have regard to this as good practice when updating their SIP.
Publication
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Publication
An employer’s ability to ask for a sick note when an employee is absent from work due to illness is becoming increasingly curtailed across Canada.
Publication
Since 2022, the Government of Canada has introduced three waves of amendments to the Competition Act (Act), making substantive changes to Canada’s competition laws, with the most recent amendments receiving royal assent on June 20, 2024.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023